Wall Street brokerages expect MannKind Co. (NASDAQ:MNKD – Get Rating) to post $15.54 million in sales for the current fiscal quarter, according to Zacks Investment Research. Three analysts have made estimates for MannKind’s earnings, with the highest sales estimate coming in at $16.40 million and the lowest estimate coming in at $14.22 million. MannKind reported […]
COPENHAGEN (dpa-AFX) - MannKind Corporation (MNKD) has entered into an agreement with Zealand Pharma A/S (ZEAL) to acquire V-Go for $10 million, with additional sales-based milestones plus the